Skip to main content

Tesamorelin vs GHRP-2

Both Tesamorelin and GHRP-2 are used for growth-hormone. Here's how their evidence, dosing, and regulatory status actually compare.

Tesamorelin

Evidence A

Tesamorelin (Egrifta)

An FDA-approved GHRH analog that stimulates natural growth hormone production. Clinically proven to reduce visceral adipose tissue and increasingly used off-label for body recomposition.

View full Tesamorelin profile →

GHRP-2

Evidence B

Growth Hormone Releasing Peptide 2

A potent synthetic ghrelin-mimetic GH secretagogue. Drives strong GH spikes but raises cortisol and prolactin more than newer alternatives like Ipamorelin.

View full GHRP-2 profile →

Side-by-Side

AttributeTesamorelinGHRP-2
Evidence GradeAB
FDA StatusFDA-approved for HIV-associated lipodystrophyNot FDA-approved — research compound; previously studied as growth hormone deficiency diagnostic
Typical Dose2 mg daily (subcutaneous)100–300 mcg, 1–3 times daily (subcutaneous)
Clinics Indexed17886
Categoriesgrowth-hormone, fat-lossgrowth-hormone, anti-aging

Key reported benefits — Tesamorelin

  • Visceral fat reduction
  • Natural GH stimulation
  • Cognitive benefit
  • Lean mass

Key reported benefits — GHRP-2

  • Strong GH release
  • Appetite stimulation
  • Muscle recovery

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons